Cargando…

Small Molecular Inhibitors Reverse Cancer Metastasis by Blockading Oncogenic PITPNM3

Most cancer‐related deaths are a result of metastasis. The development of small molecular inhibitors reversing cancer metastasis represents a promising therapeutic opportunity for cancer patients. This pan‐cancer analysis identifies oncogenic roles of membrane‐associated phosphatidylinositol transfe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zihao, Shi, Yu, Lv, Li, Chen, Jianing, Jiang, WenG., Li, Jun, Lin, Qun, Fang, Xiaolin, Gao, Jingbo, Liu, Yujie, Liu, Qiang, Xu, Xiaoding, Song, Erwei, Gong, Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762305/ https://www.ncbi.nlm.nih.gov/pubmed/36285700 http://dx.doi.org/10.1002/advs.202204649

Ejemplares similares

Attenuation of PITPNM1 Signaling Cascade Can Inhibit Breast Cancer Progression
por: Liu, Zihao, et al.
Publicado: (2021)

Pitpnm1 is expressed in hair cells during development but is not required for hearing()
por: Carlisle, F.A., et al.
Publicado: (2013)

Inhibition of miR-490-5p Promotes Human Adipose-Derived Stem Cells Chondrogenesis and Protects Chondrocytes via the PITPNM1/PI3K/AKT Axis
por: Li, Hongyi, et al.
Publicado: (2020)

Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition
por: Huang, Wei, et al.
Publicado: (2016)

Mitofusin-2 (Mfn-2) Might Have Anti-Cancer Effect through Interaction with Transcriptional Factor SP1 and Consequent Regulation on Phosphatidylinositol Transfer Protein 3 (PITPNM3) Expression
por: Tang, Tao, et al.
Publicado: (2020)

Oncogenic enhancers drive esophageal squamous cell carcinogenesis and metastasis
por: Ye, Bo, et al.
Publicado: (2021)

circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer
por: Ling, Yun, et al.
Publicado: (2022)

Oncogenic KRAS blockade therapy: renewed enthusiasm and persistent challenges
por: Tang, Daolin, et al.
Publicado: (2021)

Proto-oncogene Src links lipogenesis via lipin-1 to breast cancer malignancy
por: Song, Lintao, et al.
Publicado: (2020)

Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade
por: Lue, Hui-wen, et al.
Publicado: (2017)

Reversing oncogenic transformation with iron chelation
por: Abdelaal, Gina, et al.
Publicado: (2021)

NKILA represses nasopharyngeal carcinoma carcinogenesis and metastasis by NF-κB pathway inhibition
por: Zhang, Wei, et al.
Publicado: (2019)

E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter
por: Chu, Junjun, et al.
Publicado: (2015)

EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells
por: Cai, Tingting, et al.
Publicado: (2020)

Cyclin G2 reverses immunosuppressive tumor microenvironment and potentiates PD-1 blockade in glioma
por: Li, Sen, et al.
Publicado: (2021)

Observational study on patterns of neuromuscular blockade reversal
por: Dubovoy, Timur, et al.
Publicado: (2016)

Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade
por: Goodner, Joshua A, et al.
Publicado: (2021)

The oncogenic role of GNL3 in the progression and metastasis of osteosarcoma
por: Li, Tianyou, et al.
Publicado: (2019)

Comprehensive analysis of oncogenic fusions in mismatch repair deficient colorectal carcinomas by sequential DNA and RNA next generation sequencing
por: Wang, Jing, et al.
Publicado: (2021)

Identification of DDX31 as a Potential Oncogene of Invasive Metastasis and Proliferation in PDAC
por: Xie, Yongjie, et al.
Publicado: (2022)

Blocking the recruitment of naive CD4(+) T cells reverses immunosuppression in breast cancer
por: Su, Shicheng, et al.
Publicado: (2017)

MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma
por: Tang, Qin, et al.
Publicado: (2020)

Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
por: Zhao, Jun, et al.
Publicado: (2019)

VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene‐driven non‐small‐cell lung cancers
por: Watanabe, Hiromi, et al.
Publicado: (2021)

Oncogenes induce a reversal of replication’s fortunes
por: Short, Ben
Publicado: (2013)

MiRNAs and Cancer: Key Link in Diagnosis and Therapy
por: Shi, Yu, et al.
Publicado: (2021)

Reversion of tumor hepatocytes to normal hepatocytes during liver tumor regression in an oncogene-expressing transgenic zebrafish model
por: Li, Yan, et al.
Publicado: (2019)

Cucurbitacin I Reverses Tumor-Associated Macrophage Polarization to Affect Cancer Cell Metastasis
por: Gong, Xiaocheng, et al.
Publicado: (2023)

RFWD2 Knockdown as a Blocker to Reverse the Oncogenic Role of TRIB2 in Lung Adenocarcinoma
por: Hao, Ruimin, et al.
Publicado: (2021)

Exploring the oncogenic roles of LINC00857 in pan-cancer
por: Ren, Xiaomin, et al.
Publicado: (2022)

Loss of MHC-I antigen presentation correlated with immune checkpoint blockade tolerance in MAPK inhibitor-resistant melanoma
por: Yu, Jing, et al.
Publicado: (2022)

Novel roles of RNA-binding proteins in drug resistance of breast cancer: from molecular biology to targeting therapeutics
por: Cen, Yinghuan, et al.
Publicado: (2023)

Combination of phototherapy with immune checkpoint blockade: Theory and practice in cancer
por: Zhao, Yujie, et al.
Publicado: (2022)

Long noncoding RNA DIO3OS induces glycolytic-dominant metabolic reprogramming to promote aromatase inhibitor resistance in breast cancer
por: Chen, Xueman, et al.
Publicado: (2022)

Intracellular signaling prevents effective blockade of oncogenic gp130 mutants by neutralizing antibodies
por: Rinis, Natalie, et al.
Publicado: (2014)

Identification of immune‐related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2022)

Mechanisms of Oncogenic Cooperation in Cancer Initiation and Metastasis
por: Pedraza-Fariña, Laura G.
Publicado: (2007)

Kcnn2 blockade reverses learning deficits in the mouse model of Fetal Alcohol Spectrum Disorders
por: Mohammad, Shahid, et al.
Publicado: (2020)

MYB Proto-oncogene-like 1-TWIST1 Axis Promotes Growth and Metastasis of Hepatocellular Carcinoma Cells
por: Xie, Binhui, et al.
Publicado: (2020)

Oncogenic osteomalacia: A reversible metabolic bone disorder
por: Dhanwal, Dinesh Kumar
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_k2qnfv6kjfl6optthee67n7mmt